Gsk India Annual Report 2025
Gsk India Annual Report 2025 – 32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 . Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, .
Gsk India Annual Report 2025
Source : www.linkedin.com
EX 15.2
Source : www.sec.gov
One of the Leading Pharmaceutical Companies in India | GSK India
Source : india-pharma.gsk.com
2023 Annual Report
Source : www.gsk.com
Razia Sayed Head of Business Development for Global Health GSK
Source : sg.linkedin.com
Diversity, equity and inclusion | GSK India
Source : india-pharma.gsk.com
GSK delivers strong 2023 performance and upgrades growth outlooks
Source : www.gsk.com
clavulanate potassium market size and forecast Size, Trends and
Source : www.marketresearchintellect.com
Environment | GSK
Source : www.gsk.com
pantoprazole market size and forecast Size, Trends and Forecast
Source : www.marketresearchintellect.com
Gsk India Annual Report 2025 Praveen D’sa on LinkedIn: Proud to be a part of the GSK family.: GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of with regional and sales hubs across India. The Company is engaged interalia in the business of manufacturing distributing and trading in . View upcoming earnings forecasts and in-depth analysis of company forecasts. .